Five-Year Follow-up of a Randomized Clinical Trial Testing Mailed Nicotine Patches to Promote Tobacco Cessation

John A. Cunningham; Vladyslav Kushnir; Peter Selby; Laurie Zawertailo; Rachel F. Tyndale; Scott T. Leatherdale; Christina Schell

doi:10.1001/jamainternmed.2020.0001

Five-Year Follow-up of a Randomized Clinical Trial Testing Mailed Nicotine Patches to Promote Tobacco Cessation

John A. Cunningham^*, Vladyslav Kushnir, Peter Selby, Laurie Zawertailo, Rachel F. Tyndale, Scott T. Leatherdale, Christina Schell

^*Corresponding author for this work

Research output: Contribution to journal › Letter › peer-review

1 Citation (Scopus)

Original language	English
Pages (from-to)	792-793
Number of pages	2
Journal	JAMA Internal Medicine
Volume	180
Issue number	5
DOIs	https://doi.org/10.1001/jamainternmed.2020.0001
Publication status	Published - 9 Mar 2020

Access to Document

10.1001/jamainternmed.2020.0001

Cite this

@article{f24906082cab4f30941465711bcdce3f,

title = "Five-Year Follow-up of a Randomized Clinical Trial Testing Mailed Nicotine Patches to Promote Tobacco Cessation",

author = "Cunningham, {John A.} and Vladyslav Kushnir and Peter Selby and Laurie Zawertailo and Tyndale, {Rachel F.} and Leatherdale, {Scott T.} and Christina Schell",

note = "Funding Information: Conflict of Interest Disclosures: Dr Selby has received salary support for his research time from the Clinician Scientist program at the Department of Family and Community Medicine at the University of Toronto and from the Centre for Addiction and Mental Health; grants from Pfizer, Shoppers Drug Mart, Bhasin Consulting Fund, Patient-Centered Outcomes Research Institute, Canadian Institutes of Health, Health Canada, and Canadian Cancer Society Research Institute; honorarium from Bristol-Myers Squibb; personal fees for consulting from Pfizer Canada, Evidera Inc, Johnson & Johnson, Medcan Clinic, Miller Medical Communications, and NVision Insight Group; and personal fees for serving on advisory boards from Pfizer Canada and Johnson & Johnson. Dr Zawertiailo has received investigator-initiated grant support from Pfizer Canada. Dr Tyndale has received personal fees for consulting from Quinn Emanuel Urquhart & Sullivan and Ethismos Research; serves on the scientific advisory boards of Health Canada, the Canadian Centre on Substance Use and Addiction, and Nicosurge; and has received unrestricted funds to her institution under the Global Research Award for Nicotine Dependence funding mechanism. Dr Leatherdale is a Chair in Applied Public Health funded by the Public Health Agency of Canada in partnership with the Canadian Institutes of Health Research Institute of Neurosciences, Mental Health, and Addiction and the Institute of Population and Public Health. No other disclosures were reported. Funding Information: Funding/Support: This research is funded by grant 704949 from the Canadian Cancer Society. This research was undertaken in part thanks to funding from the Canada Research Chairs program supporting Drs Cunningham (Canada Research Chair in Addictions) and Tyndale (Canada Research Chair in Pharmacogenomics). Copyright: Copyright 2020 Elsevier B.V., All rights reserved.",

year = "2020",

month = mar,

day = "9",

doi = "10.1001/jamainternmed.2020.0001",

language = "English",

volume = "180",

pages = "792--793",

journal = "JAMA Internal Medicine",

issn = "2168-6106",

publisher = "American Medical Association",

number = "5",

}

TY - JOUR

T1 - Five-Year Follow-up of a Randomized Clinical Trial Testing Mailed Nicotine Patches to Promote Tobacco Cessation

AU - Cunningham, John A.

AU - Kushnir, Vladyslav

AU - Selby, Peter

AU - Zawertailo, Laurie

AU - Tyndale, Rachel F.

AU - Leatherdale, Scott T.

AU - Schell, Christina

N1 - Funding Information: Conflict of Interest Disclosures: Dr Selby has received salary support for his research time from the Clinician Scientist program at the Department of Family and Community Medicine at the University of Toronto and from the Centre for Addiction and Mental Health; grants from Pfizer, Shoppers Drug Mart, Bhasin Consulting Fund, Patient-Centered Outcomes Research Institute, Canadian Institutes of Health, Health Canada, and Canadian Cancer Society Research Institute; honorarium from Bristol-Myers Squibb; personal fees for consulting from Pfizer Canada, Evidera Inc, Johnson & Johnson, Medcan Clinic, Miller Medical Communications, and NVision Insight Group; and personal fees for serving on advisory boards from Pfizer Canada and Johnson & Johnson. Dr Zawertiailo has received investigator-initiated grant support from Pfizer Canada. Dr Tyndale has received personal fees for consulting from Quinn Emanuel Urquhart & Sullivan and Ethismos Research; serves on the scientific advisory boards of Health Canada, the Canadian Centre on Substance Use and Addiction, and Nicosurge; and has received unrestricted funds to her institution under the Global Research Award for Nicotine Dependence funding mechanism. Dr Leatherdale is a Chair in Applied Public Health funded by the Public Health Agency of Canada in partnership with the Canadian Institutes of Health Research Institute of Neurosciences, Mental Health, and Addiction and the Institute of Population and Public Health. No other disclosures were reported. Funding Information: Funding/Support: This research is funded by grant 704949 from the Canadian Cancer Society. This research was undertaken in part thanks to funding from the Canada Research Chairs program supporting Drs Cunningham (Canada Research Chair in Addictions) and Tyndale (Canada Research Chair in Pharmacogenomics). Copyright: Copyright 2020 Elsevier B.V., All rights reserved.

PY - 2020/3/9

Y1 - 2020/3/9

UR - http://www.scopus.com/inward/record.url?scp=85081646342&partnerID=8YFLogxK

U2 - 10.1001/jamainternmed.2020.0001

DO - 10.1001/jamainternmed.2020.0001

M3 - Letter

C2 - 32150239

AN - SCOPUS:85081646342

SN - 2168-6106

VL - 180

SP - 792

EP - 793

JO - JAMA Internal Medicine

JF - JAMA Internal Medicine

IS - 5

ER -

Five-Year Follow-up of a Randomized Clinical Trial Testing Mailed Nicotine Patches to Promote Tobacco Cessation

Access to Document

Other files and links

Cite this